Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Stacey GandlerBrand Nourishment
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Phase 1 Study of PARP Inhibitor 2X-121 Selected as Oral Presentation June 1, 2018HOERSHOLM, ...
Path Toward Submission for Accelerated Approval Tazemetostat Demonstrates Clinically Meaningful Activity in Epithelioid Sarcoma; ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email